» Articles » PMID: 20798282

Alpha-synuclein Promotes SNARE-complex Assembly in Vivo and in Vitro

Overview
Journal Science
Specialty Science
Date 2010 Aug 28
PMID 20798282
Citations 959
Authors
Affiliations
Soon will be listed here.
Abstract

Presynaptic nerve terminals release neurotransmitters repeatedly, often at high frequency, and in relative isolation from neuronal cell bodies. Repeated release requires cycles of soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)-complex assembly and disassembly, with continuous generation of reactive SNARE-protein intermediates. Although many forms of neurodegeneration initiate presynaptically, only few pathogenic mechanisms are known, and the functions of presynaptic proteins linked to neurodegeneration, such as α-synuclein, remain unclear. Here, we show that maintenance of continuous presynaptic SNARE-complex assembly required a nonclassical chaperone activity mediated by synucleins. Specifically, α-synuclein directly bound to the SNARE-protein synaptobrevin-2/vesicle-associated membrane protein 2 (VAMP2) and promoted SNARE-complex assembly. Moreover, triple-knockout mice lacking synucleins developed age-dependent neurological impairments, exhibited decreased SNARE-complex assembly, and died prematurely. Thus, synucleins may function to sustain normal SNARE-complex assembly in a presynaptic terminal during aging.

Citing Articles

Limitations and Applications of Rodent Models in Tauopathy and Synucleinopathy Research.

Szegvari E, Holec S, Woerman A J Neurochem. 2025; 169(3):e70021.

PMID: 40026260 PMC: 11874209. DOI: 10.1111/jnc.70021.


Order-to-Disorder and Disorder-to-Order Transitions of Proteins upon Binding to Phospholipid Membranes: Common Ground and Dissimilarities.

Schweitzer-Stenner R Biomolecules. 2025; 15(2).

PMID: 40001501 PMC: 11852466. DOI: 10.3390/biom15020198.


High-resolution Cryo-EM Structure Determination of a-Synuclein-A Prototypical Amyloid Fibril.

Sanchez J, Pierson J, Borcik C, Rienstra C, Wright E Bio Protoc. 2025; 15(3):e5171.

PMID: 39959285 PMC: 11825309. DOI: 10.21769/BioProtoc.5171.


Microbial Trojan Horses: Virulence Factors as Key Players in Neurodegenerative Diseases.

Grahl M, Hohl K, Smaniotto T, Carlini C Molecules. 2025; 30(3).

PMID: 39942791 PMC: 11820544. DOI: 10.3390/molecules30030687.


Direct Current Stimulation (DCS) Modulates Lipid Metabolism and Intercellular Vesicular Trafficking in SHSY-5Y Cell Line: Implications for Parkinson's Disease.

Piccoli M, Barbato L, Maiorana N, Mingione A, Raimondo F, Ghirimoldi M J Neurochem. 2025; 169(2):e70014.

PMID: 39930930 PMC: 11811683. DOI: 10.1111/jnc.70014.


References
1.
Chandra S, Chen X, Rizo J, Jahn R, Sudhof T . A broken alpha -helix in folded alpha -Synuclein. J Biol Chem. 2003; 278(17):15313-8. DOI: 10.1074/jbc.M213128200. View

2.
Chandra S, Gallardo G, Fernandez-Chacon R, Schluter O, Sudhof T . Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell. 2005; 123(3):383-96. DOI: 10.1016/j.cell.2005.09.028. View

3.
Liu C, Giasson B, Lewis K, Lee V, DeMartino G, Thomas P . A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease. J Biol Chem. 2005; 280(24):22670-8. DOI: 10.1074/jbc.M501508200. View

4.
Scheff S, Price D, Schmitt F, DeKosky S, Mufson E . Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology. 2007; 68(18):1501-8. DOI: 10.1212/01.wnl.0000260698.46517.8f. View

5.
Kahle P, Neumann M, Ozmen L, Muller V, Odoy S, Okamoto N . Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model. Am J Pathol. 2001; 159(6):2215-25. PMC: 1850592. DOI: 10.1016/s0002-9440(10)63072-6. View